The Discounted Cash Flow (DCF) valuation of Beam Therapeutics Inc (BEAM) is (133,448.86) USD. With the latest stock price at 28.90 USD, the upside of Beam Therapeutics Inc based on DCF is -461860.8%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 7.2% - 9.4% | 8.3% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (256,636.09) - (90,875.80) | (133,448.86) |
| Upside | -888114.1% - -314549.1% | -461860.8% |